REG Price sensitive 24 Aug 2026, 8:43 AM

Regis Healthcare Investor Presentation FY26

Regis Healthcare Ltd

Regis Healthcare Presents FY26 Results

Key points

  • Underlying EBITDA growth of 10%, ahead of guidance
  • Mature home occupancy at 96.0%
  • New clinical management system rolled out to most homes
  • Commissioning of Camberwell and Oxley homes
  • Acquisition of six homes from Rockpool and OC Health

Full summary

Regis Healthcare reported FY26 results with underlying EBITDA growth of 10%, surpassing guidance. The company achieved a mature home occupancy rate of 96.0%, up from 95.6% in the previous period. Key highlights include the rollout of a new clinical management system to most homes, the commissioning of Camberwell and Oxley homes, and the acquisition of six homes from Rockpool and OC Health. The company also saw an increase in total occupied bed days, net RAD cash inflow, and average advertised room prices. Regis Healthcare continues to focus on improving care delivery, investing in its people, and enabling margin improvement. The company remains well-positioned to meet increasing demand and future consumer expectations.

Guidance

Underlying EBITDA growth of 10%, ahead of guidance

Outlook

Regis Healthcare is focused on growing resident revenue, leveraging scale, and pursuing further growth. They aim to achieve this through strategic capex investments, enhancing room quality, and pursuing acquisitions of high-quality aged care businesses.

Sign in for more about this company, including guidance changes and other insights.
Sign in